Management of osteoporosis with Bonton active granules
- Conditions
- Health Condition 1: null- Osteopenic osteoporotic patients of either sex whose BMD t score is equal to or less than 1 will be selected for the present study
- Registration Number
- CTRI/2016/04/006832
- Lead Sponsor
- Vasu Research Centre VRC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Osteopenic/osteoporotic patients of either sex whose BMD (t score) is equal to or less than 1 will be selected for the present study
Patients between the age group of 40 and 70 years and willing to give consent to participate in the study
Patients whose age is below 40 and above 70 years
Patients whose BMD (t score) is above 1 will be excluded from the present study
Patients suffering from neoplasm of the bone will be excluded
Known cases of poorly controlled Hypertension or with uncontrolled Diabetes Mellitus or suffering from Thyrotoxicosis Hyper Parathyroidism Addisonâ??s disease Pagetâ??s disease Cushingâ??s SyndromeTuberculosis of the bone Osteomalacia chronic renal failure hepatic and cardiac failure will also be excluded from present clinical trial
Rheumatoid arthritis, Gouty arthritis and any long standing systemic disease will be excluded
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method